Asensus Surgical, Inc. Schedules Third Quarter Financial and Operating Results Conference Call for November 14, 2023
07 Novembro 2023 - 8:55AM
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device
company that is digitizing the interface between the surgeon and
the patient announced today that it plans to release 2023 third
quarter financial and operating results after the market closes on
Tuesday, November 14, 2023. The Company will host a conference call
to discuss these results starting at 4:30 p.m. ET the same day. The
call will be concurrently webcast.
To listen to the conference call on your telephone, please dial
1-888-886-7786 for domestic callers and 416-764-8658 for
international callers, approximately ten minutes prior to the start
time. To access the live audio webcast or archived recording, use
the following link https://ir.asensus.com/events-and-presentations.
The replay will be available on the Company’s website.
About Asensus Surgical, Inc.
Asensus Surgical, Inc. is digitizing the interface between the
surgeon and patient to pioneer a new era of Performance-Guided
Surgery™ by unlocking clinical intelligence for surgeons to enable
consistently superior outcomes and a new standard of surgery.
Based upon the foundations of digital laparoscopy and the
Senhance® Surgical System, the Company is developing the LUNA™
Surgical System, a next generation robotic and instrument system as
a foundation of its digital surgery solution. These systems will be
powered by the Intelligent Surgical Unit™ to increase surgeon
control and reduce surgical variability. With the addition of
machine vision, augmented intelligence, and deep learning
capabilities throughout the surgical experience, we intend to
holistically address the current clinical, cognitive and economic
shortcomings that drive surgical outcomes and value-based
healthcare. The Senhance Surgical System is now available for sale
in the US, EU, Japan, Russia, and select other countries. For a
complete list of indications for use, visit:
www.senhance.com/indications. To learn more about
Performance-Guided Surgery, and digital laparoscopy with the
Senhance Surgical System visit www.asensus.com..
Follow Asensus
Email Alerts: https://ir.asensus.com/email-alertsLinkedIn:
https://www.linkedin.com/company/asensus-surgical-incTwitter:
https://twitter.com/AsensusSurgicalYouTube:
https://www.youtube.com/@AsensusSurgicalVimeo:
https://vimeo.com/asxcTikTok:
https://www.tiktok.com/@asensus_surgical
INVESTOR CONTACT:Mark Klausner or Mike
VallieICR Westwickeinvest@asensus.com443-213-0499
MEDIA CONTACT:Dan VentrescaMatter
CommunicationsAsensusPR@matternow.com617-874-5488
Asensus Surgical (AMEX:ASXC)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Asensus Surgical (AMEX:ASXC)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024